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Int J Exerc Sci 2(1): S11, 2009. The Omron HBF-500 incorporates both hand-to-hand and 
foot-to-foot electrical impedance technology. At this time, the authors are not aware of 
any studies examining the consistency of this monitor. PURPOSE: To assess the 
reliability of the Omron HBF-500 body composition monitor. METHODS: Twelve men 
and six women signed an informed consent and participated in the study (32.4±8.7 
years, 169.9±7.5 cm, 81.4±15.9 kg, 28.2±5.5 kg.m-2). Participants reported to the 
laboratory on three separate occasions separated by at least one day and within one 
week. Participants were asked to refrain from exercise and caffeine on the days of 
testing and, were asked to not eat a heavy meal three hours prior and to remain 
normally hydrated. For each trial, height was measured on a Seca 214 portable height 
rod (Hamburg, Germany) and weight on a Detecto DR 400 digital platform scale (Webb 
City, MO) without shoes or socks and with one layer of light clothing. Participants then 
had their body weight and body fat percent (BF%) assessed on the Omron HBF-500 
body composition monitor. On the second day of testing, body BF% was also assessed 
using a Biodynamics 450 bioimpedance analyzer (Seattle, WA). RESULTS: There were 
no significant differences between the trials for weight assessed on the digital platform 
scale, F(2,17) = 1.2, p = 0.308, and on the Omron HBF-500, F(2,17) = 2.6, p = 0.086 (Table 
1). There were also no significant differences between the trials for body fat assessed on 
the Omron F(2,17) = 1.0, p = 0.351. Reliability assessed with Cronbach’s alpha was high 
between the trials of each of the measures (Digital scale (kg), α = 0.999, Omron (kg), α = 
0.999, Omron (BF%), α = 0.998). A dependent t-test indicated a significant difference in 
BF% between the Omron and Biodynamics analyzer (34.2±9.6 and 38.8±12.8, 
respectively), t(15) = -2.9, p = 0.011. Finally, dependent t-tests revealed body weight 
measured by the Omron was significantly greater than the Detecto scale in trial 2, t(17) 
= -6.9, p = 0.001, and in trial 3, t(17) = -7.9, p = 0.001 
Table 1. Body Weight and Body Composition Trials 
 Trial 1 Trial 2 Trial 3 
Detecto (kg) 81.4±15.9 81.3±15.7 81.7±15.4 
Omron (kg) 81.7±15.9   81.8±15.8*     82.3±15.6** 
Omron (BF%) 32.7±10.5 32.7±10.2 33.1±10.3 
*Significantly greater than Detecto (trial 2), p<.05 
**Significantly greater than Detecto (trial 3), p<.05 
 CONCLUSIONS: The Omron HBF-500 seems to consistently measure body weight 
and body composition. Although the HBF-500 can be questioned as an accurate 
measure of body composition, it seems to be a useful tool if one is interested in tracking 
changes in body weight and BF%. 
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